Patients & CaregiversHealthcare Professionals - Opens new windowWorldwide - Opens new window
HomeAbout Merck Products Newsroom Investor Information CareersResearchLicensing

The Merck Manual of Health & Aging Logo

Committed to Providing Medical Information

gray rule

Table of Contents

Index

gray rule

Enlarge Text
Reset Text
Shrink Text

gray rule

book   Buy the Book

gray rule Selected Links
 
grey line
INDEX   Index A ~ Index B ~ Index C ~ Index D ~ Index E ~ Index F ~ Index G ~ Index H ~ Index I ~ Index J ~ Index K ~ Index L ~ Index M ~ Index N ~ Index O ~ Index P ~ Index Q ~ Index R ~ Index S ~ Index T ~ Index U ~ Index V ~ Index W ~ Index X ~ Index Y ~ Index Z
grey line
 

Index G

Gabapentin: Sec. 3, Ch. 29
Gait training: Sec. 2, Ch. 13
after hip replacement: Sec. 2, Ch. 13
after stroke: Sec. 2, Ch. 13
Gait
in Parkinson's disease: Sec. 3, Ch. 30
in Shy-Drager syndrome: Sec. 3, Ch. 30
Galantamine
in dementia: Sec. 3, Ch. 27
Gallbladder scan: Sec. 2, Ch. 10
Gallium scan: Sec. 2, Ch. 10
Gangrene
with aneurysm: Sec. 3, Ch. 44
in peripheral arterial disease: Sec. 3, Ch. 44
Garlic: Sec. 2, Ch. 7
drug interactions with: Sec. 2, Ch. 7
Gas
with dairy products: Sec. 1, Ch. 2
Gastroenteritis: Sec. 3, Ch. 55; Sec. 3, Ch. 55
Gastroenterologist: Sec. 2, Ch. 9
Gastroesophageal reflux disease (GERD): Sec. 3, Ch. 54; Sec. 3, Ch. 54; Sec. 3, Ch. 54
Gay relationships: Sec. 4, Ch. 63
Gemfibrozil: Sec. 3, Ch. 44
Genetic testing: Sec. 2, Ch. 10
Genitals
female: Sec. 3, Ch. 58
GERD: (see Gastroesophageal reflux disease)
Geriatric care manager: Sec. 2, Ch. 9
Geriatrician: Sec. 2 Ch. 09 [sidebar]; Sec. 2, Ch. 11
Gerontologist: Sec. 2 Ch. 09 [sidebar]
Giant cell arteritis: Sec. 3, Ch. 42
blood clots with: Sec. 3, Ch. 49
Ginger: Sec. 2, Ch. 7
drug interactions with: Sec. 2, Ch. 7
Gingivitis: Sec. 3, Ch. 39
Ginkgo biloba: Sec. 2, Ch. 7
drug interactions with: Sec. 2, Ch. 7; Sec. 2, Ch. 7
Ginkgo biloba
in dementia: Sec. 3, Ch. 27
Ginseng: Sec. 2, Ch. 7
drug interactions with: Sec. 2, Ch. 7
Glare
sensitivity to: Sec. 1, Ch. 2
Glasses
reading: Sec. 1, Ch. 2
Glaucoma: Sec. 3, Ch. 36
dizziness and: Sec. 3, Ch. 20
Gleason score: Sec. 3, Ch. 51
Glimepiride: Sec. 3, Ch. 34
Glipizide: Sec. 3, Ch. 34
Glucagon: Sec. 3, Ch. 34
Glucosamine: Sec. 2, Ch. 7
in osteoarthritis: Sec. 3, Ch. 41
Glucose
blood: (see Blood sugar)
     levels of
Glucosidase inhibitors: Sec. 3, Ch. 34; Sec. 3, Ch. 34
Glyburide: Sec. 3, Ch. 34
Glycoprotein IIb/IIIa inhibitors: Sec. 3, Ch. 45
Goiter: Sec. 3, Ch. 33
multinodular: Sec. 3, Ch. 33; Sec. 3, Ch. 33; Sec. 3, Ch. 33; Sec. 3, Ch. 33
Gold compounds: Sec. 3, Ch. 41
Goldenseal: Sec. 2, Ch. 7
drug interactions with: Sec. 2, Ch. 7
Goniometry: Sec. 2, Ch. 13
Goserelin: Sec. 3, Ch. 51
Gout: Sec. 3, Ch. 41
vs. pseudogout: Sec. 3, Ch. 41
Grab bars: Sec. 3, Ch. 21
Grafts
in aortic repair: Sec. 3, Ch. 44
in coronary artery bypass: Sec. 3, Ch. 45
in pressure sores: Sec. 3, Ch. 35
in venous ulcers: Sec. 3, Ch. 35
Graves' disease: Sec. 3, Ch. 33; Sec. 3, Ch. 33; Sec. 3, Ch. 33
Grieving: Sec. 4, Ch. 61
information resources on: 884-885
sleep disturbance and: Sec. 3, Ch. 31
Growth hormone (human): Sec. 2, Ch. 7
aging-related changes in: Sec. 3, Ch. 17
Growth hormone
aging-related changes in: Sec. 1, Ch. 2
Gryphosis: Sec. 3, Ch. 40
Guillain-Barré syndrome
in influenza: Sec. 3, Ch. 52; Sec. 3, Ch. 52
Gums
drug-related growth of: Sec. 3, Ch. 39
inflammation of (gingivitis): Sec. 3, Ch. 39
recession of: Sec. 1, Ch. 2
Gustatory rhinitis: Sec. 3, Ch. 38
Gynecologists: Sec. 2, Ch. 9
Contact Merck Site MapPrivacy PolicyTerms of UseCopyright 1995-2008 Merck & Co., Inc.